Suppr超能文献

舒芬太尼作为罗哌卡因辅助药物用于剖宫产,以缓解瘢痕子宫产妇硬膜外麻醉下躯体 - 内脏疼痛的剂量反应。

The dose response of sufentanil as an adjuvant to ropivacaine in cesarean section for relief from somato-visceral pain under epidural anesthesia in parturients with scarred uterus.

作者信息

Lu Qiang, Dong Chun-Shan, Yu Jun-Ma, Sun Hao, Sun Peng, Ma Xiang, Luo Chun

机构信息

Department of Anaesthesiology, Third affiliated hospital of Anhui Medical University.

出版信息

Medicine (Baltimore). 2018 Sep;97(38):e12404. doi: 10.1097/MD.0000000000012404.

Abstract

Visceral pain is common during epidural anesthesia with mini dose local anesthetics in parturients during cesarean section. To reduce or avoid this complication caused by traction on the abdominal viscera, this study aimed to determine the 50% effective dose (ED50) and 95% effective dose (ED95) of epidural sufentanil as an adjuvant combination with local anesthetics for relief visceral pain in parturients with scarred uterus undergoing elective cesarean section.One hundred parturients with scarred uterus undergoing elective cesarean section under epidural anesthesia were enrolled in this randomized, double-blinded, dose-ranging study. Parturients received 5, 10, 15, 20, and 25 μg epidural sufentanil as an adjuvant with 10 mL of 0.65% ropivacaine. Successful epidural anesthesia was defined as a sixth thoracic vertebra (T6) sensory level achieved within 20 minutes after epidural drugs administration and/or no visceral pain by traction on the abdominal viscera during the cesarean section. The ED50 and ED95 were calculated with a logistic regression model.ED50 and ED95 of epidural sufentanil for successful of the pain-free from visceral pain were 10.7 μg [95% confidence interval (CI): 2.4-14.4 μg) and 28.1 μg (95% CI: 19.4-44.0 μg), respectively. The onset time to sensory block, maximum Bromage scale and duration of motor block were significant different with dose of sufentanil >20 μg (P < .05, compared with the other dose groups). With the dose of epidural sufentanil >20 μg could result in an increase of incidence of maternals' adverse effects. Compared with a different dose of sufentanil, epidural administed sufentanil between 15 μg and 20 μg can maximize parturients' satisfaction.Our study showed that sufentanil could be used in combination with ropivacaine for relief from somato-visceral pain in patients with scarred uterus during elective cesarean section during epidural anesthesia, and that maximized parturients' satisfaction could be achieved when the use of sufentanil with the dose between 15 μg and 20 μg for epidural anesthesia.

摘要

剖宫产时,小剂量局麻药硬膜外麻醉期间产妇常出现内脏痛。为减少或避免因牵拉腹腔脏器引起的这一并发症,本研究旨在确定硬膜外给予舒芬太尼作为辅助用药与局麻药联合使用时,用于缓解择期剖宫产瘢痕子宫产妇内脏痛的半数有效剂量(ED50)和95%有效剂量(ED95)。100例择期剖宫产瘢痕子宫产妇纳入本随机、双盲、剂量范围研究,产妇接受5、10、15、20和25μg硬膜外舒芬太尼作为10mL 0.65%罗哌卡因的辅助用药。成功的硬膜外麻醉定义为硬膜外给药后20分钟内达到第六胸椎(T6)感觉平面和/或剖宫产期间牵拉腹腔脏器无内脏痛。采用逻辑回归模型计算ED50和ED95。硬膜外舒芬太尼用于成功缓解内脏痛的ED50和ED95分别为10.7μg[95%置信区间(CI):2.4 - 14.4μg]和28.1μg(95%CI:19.4 - 44.0μg)。感觉阻滞起效时间、最大布罗玛格评分和运动阻滞持续时间在舒芬太尼剂量>20μg时与其他剂量组有显著差异(P<0.05)。硬膜外舒芬太尼剂量>20μg会导致产妇不良反应发生率增加。与不同剂量舒芬太尼相比,硬膜外给予15μg至20μg舒芬太尼可使产妇满意度最大化。我们的研究表明,舒芬太尼可与罗哌卡因联合用于硬膜外麻醉下择期剖宫产瘢痕子宫患者的躯体 - 内脏痛缓解,硬膜外麻醉使用15μg至20μg舒芬太尼时可使产妇满意度最大化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d346/6160163/65f7ecf8ac2d/medi-97-e12404-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验